Skip to Content

Benztropine Mesylate Injection

Last Updated: April 21, 2020
Status: Current

Products Affected - Description
    • Cogentin injection, Akorn, 1 mg/mL, 2 mL ampule, 5 count, NDC 76478-0611-02
    • Benztropine Mesylate injection, Akorn, 1 mg/mL, 2 mL ampule, 5 count, NDC 17478-0012-02
    • Benztropine Mesylate injection, Fresenius Kabi, 1 mg/mL, 2 mL vial, 5 count, NDC 63323-0970-02
Reason for the Shortage
    • Akorn is not marketing benztropine 1 mg/mL 2 mL ampules and Cogentin 1 mg/mL 2 mL ampules.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Benztropine Mesylate injection, Hikma, 1 mg/mL, 2 mL ampule, 5 count, NDC 00143-9729-05

Estimated Resupply Dates

    • Fresenius Kabi has short-dated benztropine 1 mg/mL 2 mL vials available with an expiration date of <7 months.

Updated

Updated April 21, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 30, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide